Article Listing

Mar 5, 2020
Originally published February 24, 2020 The Epilepsy Foundation Wellness Institute believes that everyone deserves to live a full and productive life and is dedicated to providing resources to promote well-being. We are pleased to premiere our next...
drug news
Mar 3, 2020
  Valtoco®, a rescue medicine that delivers diazepam through the nose, was approved earlier this year by the U.S. Food and Drug Administration (FDA). It is available in pharmacies now. Valtoco is prescribed to help stop periods of increased...
Epilepsy Centers
Feb 29, 2020
  Dr. Nathan Fountain is the previous president of the National Association of Epilepsy Centers (NAEC), a trade organization representing over 240 epilepsy centers in the United States. In 2019, we asked Dr. Fountain to reflect on what the...
Drug Alert
Feb 25, 2020
Update: February 25, 2020 The Epilepsy Foundation has stayed in contact with the agency in the U.S. Food and Drug Administration (FDA) that handles drug shortages. The agency has been proactively working with the manufacturers of levetiracetam (...
Medication alert about recall
Feb 21, 2020
On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a company alert about a voluntary recall of lamotrigine 100 mg tablets from Taro Pharmaceuticals. Lamotrigine 100 mg tablets from lot # 331771 are being recalled due to...

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline